# The Human Medicines Regulations 2012, Paragraph 1


A medicinal product that contains aloxiprin, aspirin or paracetamol (or, where appropriate, any combination of those substances) and that is in the form specified in column 1 of the following table must be presented for sale in a separate and individual package containing not more than the amount of the product specified in the corresponding entry in column 2—
Column 1
Column 2
Effervescent tablets—
(a) that do not contain aspirin, or
(b) that do not contain more than 325 milligrams of aspirin per tablet.
30 tablets
Effervescent tablets—
(a) that contain more than 325 milligrams of aspirin per tablet, but
(b) that do not contain more than 500 milligrams per tablet.
20 tablets
Non-effervescent tablets—
(a) that are enteric-coated,
(b) that contain aspirin only, and
(c) that do not contain more than 75 milligrams per tablet.
28 tablets
Other non-effervescent tablets
16 tablets
Powder or granules
10 sachets
Capsules
16 capsules
Liquid preparations of paracetamol intended for persons aged 12 years and over
160 millilitres
Liquid preparations of paracetamol intended for persons aged less than 12 years
Individual unit doses of not more than 5 millilitres each, to a maximum of 20 unit doses

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/15/paragraph/1 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-15/paragraph-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.